Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,560 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02079389 | The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum | completed | N/A | 280 | Odense University HospitalOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01092078 | Community-based Approaches to Treating Hypertension and Colon Cancer Prevention(MISTER-B) | completed | N/A | 740 | NYU Langone HealthOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00032110 | Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00077298 | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00826800 | Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer | terminated | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01882972 | Strength for Health | withdrawn | N/A | 0 | Loyola UniversityOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00551421 | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2015 | clinicaltrials |
| NCT01440127 | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers | terminated | Phase 1 | 9 | Tufts Medical CenterOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT01378013 | SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study(SaMPLE) | completed | — | 50 | Imperial College LondonOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT00826579 | Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer | completed | Phase 1 / Phase 2 | 192 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 12, 2015 | clinicaltrials |
| NCT01358812 | FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer(TRIP) | completed | Phase 2 | 37 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01547130 | Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation | completed | Phase 1 / Phase 2 | 133 | Arya, Vijaypal, M.D., P.C.INDIV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00103311 | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 2, 2015 | clinicaltrials |
| NCT01831245 | Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol | completed | — | 125 | Karolinska InstitutetOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT02331641 | Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. | completed | — | 554 | University of MilanOTHER | 0 | Jan 6, 2015 | clinicaltrials |
| NCT02326727 | Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery | unknown | N/A | 30 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Dec 29, 2014 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00972036 | Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy | completed | Phase 1 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT00975247 | Impact of a Novel Patient Educational Booklet on Colonoscopy Quality | completed | N/A | 500 | VA Greater Los Angeles Healthcare SystemFED | 1 | Dec 10, 2014 | clinicaltrials |
| NCT02308631 | Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Laparotomy(EACC) | completed | Phase 1 | 5 | University of Sao PauloOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01003600 | Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information | completed | — | 177 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02305368 | Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4(Oncogramme) | completed | — | 20 | University Hospital, LimogesOTHER | 0 | Dec 2, 2014 | clinicaltrials |
| NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer(TOSCA) | completed | Phase 3 | 3,756 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Nov 26, 2014 | clinicaltrials |
| NCT02288611 | The Impact of Palm Date Intake on Colon Health Biomarkers(AJWA) | completed | N/A | 22 | University of ReadingOTHER | 0 | Nov 11, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT02280278 | Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy | unknown | Phase 3 | 550 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01801059 | Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer | completed | N/A | 284 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01149434 | Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers | terminated | Phase 1 / Phase 2 | 19 | University of UtahOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT02253303 | Evaluation of the Extraction-site, - Midline Incision vs Off-midline Incision- | unknown | N/A | 100 | Hiroki YamaueOTHER | 0 | Oct 1, 2014 | clinicaltrials |
| NCT02250196 | A Randomized Prospective Trial Comparing Low-volume Bowel Preparation Methods | completed | Phase 3 | 200 | Korea University Anam HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT00433576 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Sep 15, 2014 | clinicaltrials |
| NCT01365910 | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer | terminated | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT01535326 | Comparing Water Immersion and Water Exchange Methods During Minimally Sedated Colonoscopy | completed | N/A | 270 | Dalin Tzu Chi General HospitalOTHER | 1 | Aug 15, 2014 | clinicaltrials |
| NCT02066259 | OctavaColon Cancer Blood Tests OctavaGold and OctavaSilver - Blood Tests for the Help in Diagnosis of Colon Cancer Clinical Study Protocol | unknown | — | 1,080 | Eventus Diagnostics LtdINDUSTRY | 1 | Aug 5, 2014 | clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | terminated | Phase 3 | 72 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT00892593 | Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing(ASC-FIT) | unknown | N/A | 4,100 | Forsyth Medical CenterOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01941173 | Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00393822 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | completed | Phase 2 / Phase 3 | 100 | AmgenINDUSTRY | 0 | Jul 15, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00256334 | Resveratrol for Patients With Colon Cancer | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT02164149 | Length of Tumour Feeding Artery After Colon Cancer Surgery(ColonCT) | unknown | — | 65 | University of AarhusOTHER | 1 | Jun 16, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT01005225 | Genetic Investigation of Solid Tumors Cohort | completed | — | 25 | Scripps Translational Science InstituteOTHER | 1 | Jun 12, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00675012 | NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 24 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 5, 2015source: clinicaltrials